1-(3-tert-butyl-1-pyridin-3-ylpyrazol-5-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea
C26H23FN8O3 — CID 155586372
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3-tert-butyl-1-pyridin-3-ylpyrazol-5-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea
1-(3-tert-butyl-1-pyridin-3-ylpyrazol-5-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea (PubChem CID 155586372) has the molecular formula C26H23FN8O3 and a molecular weight of 514.52 g/mol. Its IUPAC name is 1-(3-tert-butyl-1-pyridin-3-ylpyrazol-5-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea.
Molecular Properties
| Compound Name | 1-(3-tert-butyl-1-pyridin-3-ylpyrazol-5-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea |
|---|---|
| PubChem CID | 155586372 |
| Molecular Formula | C26H23FN8O3 |
| Molecular Weight | 514.52 g/mol |
| Exact Mass | 514.19 |
| IUPAC Name | 1-(3-tert-butyl-1-pyridin-3-ylpyrazol-5-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea |
| SMILES | CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(-c2cccnc2)n1 |
| InChI | InChI=1S/C26H23FN8O3/c1-26(2,3)20-12-21(35(34-20)15-5-4-9-28-13-15)32-25(37)31-18-7-6-16(11-17(18)27)38-19-8-10-29-24-23(19)30-14-22(36)33-24/h4-14H,1-3H3,(H,29,33,36)(H2,31,32,37) |
| InChIKey | JVTOZQXDDROEQN-UHFFFAOYSA-N |
| XLogP | 4.77 |
| TPSA | 139.71 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 514.52 |
| LogP ≤ 5 | 4.77 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155586372 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.